April 28–29, 2026
Kerry Hotel Pudong, Shanghai, ChinaMay 6–7, 2026 - Digital Partnering Yelin ChenFounder at Synphatec (Shanghai) Biopharmaceutical TechnologyPresenter
Profile
Founded in 2022 in Shanghai, foucusing on CNS therapeutic area Leading Assets: Fast-Antidepressant & Broad spectrum AD therapeutics Has accumulated over $13 million in financing Drug discovery based on the understanding of brain disease biology or drug mechanism from the founder’s lab Exclusive intelligent property rights officially transferred to the company